Catalyst Wire Dossier Catalyst Wire Dossier

Lispro Mid Mixture (MM)

insulin lispro · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lispro Mid Mixture (MM), covering 2010-04-27 to 2010-04-27. Get the full timeline:

Most recent: Clinical Trial Update: Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) [Phase 4]

See pricing